Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
San Francisco
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The Citadel Embolization Device Study
The purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular’s Next Generation Target Detachable Coil (hereafter referred to as the Citadel Embolization Device), when used with Target Detachable Coils, in the treatment of wide-neck intracranial aneurysms.
Location: CPMC (San Francisco: Davies Campus)
Please contact: ClinicalResearch@sutterhealth.org about study CITADEL
Principal Investigator
Co-Investigator(s)
Fabio Settcase, M.D., M.S., FRCPC, Warren T Kim, M.D., Ph.D.